Molecular Partners Q3 EPS $(0.38) Beats $(0.46) Estimate
Benzinga Newsdesk 3 weeks ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.46) by 17.39 percent. This is a 76.97 percent increase over losses of $(1.65) per share
Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.46) by 17.39 percent. This is a 76.97 percent increase over losses of $(1.65) per share from the same period last year.
